AMANDA HOTOVY: Open Payments
NPI 1275027823 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,486 in 107 payments from 18 companies in 2025. Trend: 2023 $2,132 · 2024 $1,502 · 2025 $2,486
Food & beverage: $2,025Education: $461
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $398 |
| Janssen Biotech, Inc. | 10 | $352 |
| Novartis Pharmaceuticals Corporation | 11 | $294 |
| GENZYME CORPORATION | 10 | $219 |
| UCB, Inc. | 9 | $186 |
| E.R. Squibb & Sons, L.L.C. | 11 | $181 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| Lilly USA, LLC | 8 | $134 |
| PFIZER INC. | 2 | $123 |
| ABBVIE INC. | 6 | $121 |
Products named: DUPIXENT, TREMFYA, ILUMYA, COSENTYX, Bimzelx, Sotyktu, TALTZ, LITFULO.
Industry payments across NE — which companies pay providers there.
